Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation Academic Article uri icon

Overview

MeSH Major

  • Cardiomyoplasty
  • Cell Transplantation
  • Fetal Heart
  • Myocytes, Cardiac

abstract

  • Pretreatment of an infarcted region of the heart with angiogenic mediators such as VEGF can enhance the efficacy of cellular cardiomyoplasty, presumably by creating a more favorable environment for the survival of transplanted cells.

publication date

  • April 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jtcvs.2003.09.049

PubMed ID

  • 15052201

Additional Document Info

start page

  • 1041

end page

  • 9; discussion 1049-51

volume

  • 127

number

  • 4